Condition: Von Willebrand Diseases · Sponsor: University Hospital, Brest
Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature. The aim of the study is to describe the frequency and nature of arterial and venous thromboembolic events and atrial fibrillation in patients with von Willebrand disease in the West of France. The investigators will perform a retrospective multicenter study conducted in the von Willebrand population of the French West. Von Willebrand adult patients followed in one of the French West medical centers participating in the study, who presented deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, atrial fibrillation, arteriopathy of the lower limbs, angina will be eligible.
This description comes directly from the study's public registry record.
Brigitte PAN PETESCH · 02.98.22.36.50 · brigitte.pan-petesch@chu-brest.fr
Sara ROBIN · sara.robin@chu-brest.fr
Always discuss trial participation with your own doctor first.
| CHU d'Angers | Angers, France | Not Yet Recruiting |
| CHU de Brest | Brest, France | Recruiting |
| CHU de Caen | Caen, France | Not Yet Recruiting |
| CH le MANS | Le Mans, France | Not Yet Recruiting |
| CHU de Nantes | Nantes, France | Not Yet Recruiting |
| CHU de Rennes | Rennes, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05773638